DNA-Guided drugs battle advanced cancer in new trial
NCT ID NCT07346209
Summary
This study aims to see if cancer drugs chosen to match a patient's specific tumor DNA mutations work better than standard treatments. It will involve 280 adults with advanced, hard-to-treat cancers that have spread or cannot be removed by surgery. Researchers will compare how long the cancer is kept from getting worse between patients receiving these personalized drug matches and those receiving standard care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of California, San Diego
La Jolla, California, 92093, United States
Conditions
Explore the condition pages connected to this study.